DealScout · The Coverage Engine

Buyer coverage,
signal-ranked, source-backed.

Buyer coverage stays inside the live process.

DealScout indexes your firm's historical deals, precedent transactions, and buyer universe — then ranks outreach, NDA status, and buyer activity by momentum, not by the spreadsheet someone last updated three weeks ago.

Precedent Transaction Search Buyer Universe Build IOI Tracker Coverage Priority Matrix Tombstone Generator Reactivation Signals Sponsor & Strategic Strip Profile
Try Magnum See Search Demo
The Scenario

Win the pitch with intel your
competitor doesn't have.

Sunday, 8:30 PM — Pitch tomorrow at 9
You're pitching a $400M medtech company exploring a sale. Management is meeting with three other banks this week. You need the last three years of comparable transactions with EV/Revenue and EV/EBITDA spreads, a fit-scored buyer universe (strategics — Medtronic, Stryker, J&J — plus PE sponsors with healthcare theses), and your firm's healthcare M&A credentials page.

The data exists — scattered across old pitch books on SharePoint, precedent transaction spreadsheets on shared drives, and deal context in people's heads from past mandates. Assembling it the manual way takes 4-6 hours the team does not have on a Sunday night.

With DealScout, the query "Healthcare M&A > $500M, last 3 years" returns a source-tagged precedent set, a fit-scored buyer universe, and an auto-formatted credentials page inside 30 seconds. The MD walks into Monday's pitch with intel three other banks did not have time to assemble.
Live Search

Ask anything about deals.

Natural language search across precedent transactions, market data, and your firm's historical deals.

Healthcare M&A deals >$500M in last 3 years
Healthcare >$500M 2023-2026 M&A 24 results in 0.8s
Medtronic / Mazor Robotics
Strategic acquisition — Surgical robotics platform, Israel-based
$1.7B Dec 2023 Medtech Strategic
EV/Rev8.2x EV/EBITDA28.4x
J&J / Abiomed
Heart support devices — Premium acquisition with earn-out
$16.6B Mar 2024 Cardiovascular Strategic
EV/Rev31.5x EV/EBITDAn/a
EQT / Galderma (IPO)
Dermatology platform — Swiss IPO after PE ownership
$22B EV Jun 2024 Specialty Pharma IPO/Exit
EV/Rev5.1x EV/EBITDA22.0x
Thermo Fisher / Olink Proteomics
Proteomics diagnostics — Sweden-based, all-cash deal
$3.1B Oct 2024 Diagnostics Strategic
EV/Rev14.8x EV/EBITDAn/m
Capabilities

Stop reinventing the wheel.

Deal Intelligence Search
Natural language search across public and proprietary deal data. Filter by industry, size, date, type, geography. Get formatted results with multiples and deal terms.
Credential Generator
"Show me our healthcare M&A credentials." Instantly generates tombstone pages from your historical deals. Formatted, branded, pitch-ready. No more digging through old decks.
Buyer Universe Builder
Input a target company. AI generates a scored list of 25+ potential buyers with strategic rationale, financial capacity, geographic fit, and recent M&A activity. Strategic + PE.
Institutional Memory
Index all past CIMs, pitch books, models, and memos. Preserve deal context. "Why did we structure that deal this way?" Knowledge that used to leave when people did.

Walk into the pitch with intel three other banks couldn't assemble.

Run a precedent transaction search, generate a fit-scored buyer universe, and assemble a healthcare M&A credentials page on demo data — in 30 seconds.

Try Magnum